Clear Alpha Technologies LP Sage Therapeutics, Inc. Transaction History
Clear Alpha Technologies LP
- $158 Billion
- Q1 2025
A detailed history of Clear Alpha Technologies LP transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Clear Alpha Technologies LP holds 40,000 shares of SAGE stock, worth $264,400. This represents 0.2% of its overall portfolio holdings.
Number of Shares
40,000Holding current value
$264,400% of portfolio
0.2%Shares
1 transactions
Others Institutions Holding SAGE
# of Institutions
219Shares Held
51.6MCall Options Held
220KPut Options Held
312K-
Black Rock Inc. New York, NY5.22MShares$34.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$33.6 Million0.0% of portfolio
-
Madison Avenue Partners, LP New York, NY4.48MShares$29.6 Million4.6% of portfolio
-
Tig Advisors, LLC New York, NY2.73MShares$18.1 Million1.36% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.09MShares$13.8 Million0.02% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $393M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...